{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:01:16Z","timestamp":1791820876553,"version":"4.3.4"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic cancer is a leading cause of cancer-related deaths globally, with rapidly increasing incidence and mortality rates in several regions. This study provides a comparative analysis of pancreatic cancer trends in China, Korea, Japan, and the USA, and projects these trends through 2030.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from the Global Burden of Disease (GBD) study were used to examine trends in age-standardized incidence rates (ASIR), age-standardized mortality rates (ASMR), and disability-adjusted life years (DALYs) from 1990 to 2020. Joinpoint regression and age-period cohort (APC) models were employed to assess temporal trends. Future predictions of ASIR, ASMR, and DALYs were generated using predictive modeling to extend the analysis to 2030.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study found that Japan and the USA have the highest incidence and mortality rates for pancreatic cancer, with predicted ASIR values expected to exceed 15 per 100,000 in Japan by 2030. Mortality trends follow a similar pattern, with males consistently showing higher ASMR than females across all regions. China is expected to see continued growth in DALYs, particularly among males, while Korea exhibits stable or slightly declining trends. The longitudinal age curves indicate that pancreatic cancer rates rise significantly with age, especially in individuals over 65 years. By 2030, Japan and the USA are projected to experience the greatest increase in pancreatic cancer burden, while Korea\u2019s trends remain relatively stable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pancreatic cancer continues to pose a significant public health challenge, particularly in aging populations. The predicted rise in incidence, mortality, and DALYs in Japan and the USA calls for urgent implementation of targeted screening and prevention strategies, particularly for older age groups and high-risk populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0337181","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T18:32:37Z","timestamp":1765477957000},"page":"e0337181","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Global trends and future predictions of pancreatic cancer incidence and mortality from 1990 to 2030: A comparative analysis of China, Korea, Japan, and the USA"],"prefix":"10.1371","volume":"20","author":[{"given":"Kun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunhu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1977-6362","authenticated-orcid":true,"given":"Chenyou","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"pone.0337181.ref001","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","DOI":"10.3322\/caac.21590"},{"issue":"1","key":"pone.0337181.ref002","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41392-024-01872-7","article-title":"Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer","volume":"9","author":"P Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"27","key":"pone.0337181.ref003","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm9071","article-title":"Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy","volume":"10","author":"D Hughes","year":"2024","journal-title":"Sci Adv"},{"issue":"11","key":"pone.0337181.ref004","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"DP Ryan","year":"2014","journal-title":"N Engl J Med"},{"issue":"16","key":"pone.0337181.ref005","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"C Feig","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"7","key":"pone.0337181.ref006","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/ijms18071338","article-title":"Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies","volume":"18","author":"A Adamska","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0337181.ref007","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"pone.0337181.ref008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors","volume":"10","author":"P Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"pone.0337181.ref009","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"W Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"pone.0337181.ref010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4143\/crt.2020.206","article-title":"Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017","volume":"52","author":"S Hong","year":"2020","journal-title":"Cancer Res Treat"},{"issue":"8","key":"pone.0337181.ref011","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008-2030): a population-based study","volume":"13","author":"F Bray","year":"2012","journal-title":"Lancet Oncol"},{"issue":"9414","key":"pone.0337181.ref012","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","article-title":"Pancreatic cancer","volume":"363","author":"D Li","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"pone.0337181.ref013","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/j.gastro.2013.01.068","article-title":"The epidemiology of pancreatitis and pancreatic cancer","volume":"144","author":"D Yadav","year":"2013","journal-title":"Gastroenterology"},{"issue":"12","key":"pone.0337181.ref014","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study","volume":"5","author":"Global Burden of Disease Cancer Collaboration","year":"2019","journal-title":"JAMA Oncol"},{"issue":"11","key":"pone.0337181.ref015","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study","volume":"4","author":"Global Burden of Disease Cancer Collaboration","year":"2018","journal-title":"JAMA Oncol"},{"issue":"3","key":"pone.0337181.ref016","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"HJ Kim","year":"2000","journal-title":"Stat Med"},{"key":"pone.0337181.ref017","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"17","key":"pone.0337181.ref018","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"M Hidalgo","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0337181.ref019","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","article-title":"Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study","volume":"20","author":"M Arnold","year":"2019","journal-title":"Lancet Oncol"},{"issue":"11","key":"pone.0337181.ref020","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"L Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"pone.0337181.ref021","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global Burden of 5 Major Types of Gastrointestinal Cancer","volume":"159","author":"M Arnold","year":"2020","journal-title":"Gastroenterol"},{"issue":"3","key":"pone.0337181.ref022","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","article-title":"Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer","volume":"160","author":"J Huang","year":"2021","journal-title":"Gastroenterol"},{"issue":"10242","key":"pone.0337181.ref023","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"JD Mizrahi","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"pone.0337181.ref024","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/j.1572-0241.2007.01510.x","article-title":"Risk factors for pancreatic cancer: case-control study","volume":"102","author":"MM Hassan","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"pone.0337181.ref025","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/JS9.0000000000001054","article-title":"Global, regional, and national burdens of early onset pancreatic cancer in adolescents and adults aged 15-49 years from 1990 to 2019 based on the Global Burden of Disease Study 2019: a cross-sectional study","volume":"110","author":"Z Li","year":"2024","journal-title":"Int J Surg"},{"issue":"44","key":"pone.0337181.ref026","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.3748\/wjg.v22.i44.9694","article-title":"Epidemiology of pancreatic cancer","volume":"22","author":"M Ilic","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"2","key":"pone.0337181.ref027","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bpg.2005.10.001","article-title":"Epidemiology and risk factors for pancreatic cancer","volume":"20","author":"AB Lowenfels","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"pone.0337181.ref028","article-title":"Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019","volume":"10","author":"Y Zhang","year":"2022","journal-title":"Frontiers in Public Health"},{"issue":"4","key":"pone.0337181.ref029","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/STROKEAHA.122.040848","article-title":"Different Changing Patterns for Stroke Subtype Mortality Attributable to High Sodium Intake in China During 1990 to 2019","volume":"54","author":"Y Wang","year":"2023","journal-title":"Stroke"},{"issue":"3","key":"pone.0337181.ref030","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/CEJ.0000000000000855","article-title":"Epidemiological trend of lung cancer burden caused by residential radon exposure in China from 1990 to 2019","volume":"33","author":"C Wang","year":"2024","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"pone.0337181.ref031","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ckj\/sfac218","article-title":"Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019","volume":"16","author":"Y Li","year":"2022","journal-title":"Clin Kidney J"},{"issue":"9063","key":"pone.0337181.ref032","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study","volume":"349","author":"CJ Murray","year":"1997","journal-title":"Lancet"},{"key":"pone.0337181.ref033","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"pone.0337181.ref034","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/bjc.2011.430","article-title":"Cancer incidence in the United Kingdom: projections to the year 2030","volume":"105","author":"M Mistry","year":"2011","journal-title":"Br J Cancer"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T18:32:43Z","timestamp":1765477963000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337181"}},"subtitle":[],"editor":[{"given":"Ahmed Mustafa","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0337181","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]}}}